Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.11, n°9 - September 2019
Paru le :
01/09/2019
Année
2019
Page(s) :
1277-1580
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
ANALYSE CHIMIQUE
;
CANNABINOIDES
;
DEPISTAGE
;
COCAINE
;
CHEMSEX
;
DROGUES DE SYNTHESE
;
TOXICOLOGIE
Note de contenu :
SELECTION :
- Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds. Fabregat-Safont D., Mardal M., Noble C., Cannaert A., Stove C.P., Sancho J.V., et al., p. 1358-1368.
- Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine. Staeheli S.N., Veloso V.P., Bovens M., Bissig C., Kraemer T., Poetzsch M., p. 1369-1376.
- Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens. Haschimi B., Mogler L., Halter S., Giorgetti A., Schwarze B., Westphal F., et al., p. 1377-1386.
- Detection of cocaine and its metabolites in whole blood and plasma following a single dose, controlled administration of intranasal cocaine. Menzies E.L., Archer J.R.H., Dargan P.I., Parkin M.C., Yamamoto T., Wood D.M., et al., p. 1419-1430.
- Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders. Duflot T., Vasse M., Guillerme J., Schrapp A., Mory C., Imbert L., et al., p. 1453-1459.
- A fatal chemsex case involving gamma-butyrolactone and 4-methylethcathinone. Pellegrini M., Bolino G., Vari M.R., Giorgetti R., Pichini S., Busardo F.P., p. 1465-1470.
- Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds. Fabregat-Safont D., Mardal M., Noble C., Cannaert A., Stove C.P., Sancho J.V., et al., p. 1358-1368.
- Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine. Staeheli S.N., Veloso V.P., Bovens M., Bissig C., Kraemer T., Poetzsch M., p. 1369-1376.
- Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens. Haschimi B., Mogler L., Halter S., Giorgetti A., Schwarze B., Westphal F., et al., p. 1377-1386.
- Detection of cocaine and its metabolites in whole blood and plasma following a single dose, controlled administration of intranasal cocaine. Menzies E.L., Archer J.R.H., Dargan P.I., Parkin M.C., Yamamoto T., Wood D.M., et al., p. 1419-1430.
- Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders. Duflot T., Vasse M., Guillerme J., Schrapp A., Mory C., Imbert L., et al., p. 1453-1459.
- A fatal chemsex case involving gamma-butyrolactone and 4-methylethcathinone. Pellegrini M., Bolino G., Vari M.R., Giorgetti R., Pichini S., Busardo F.P., p. 1465-1470.
Cote :
Abonnement